Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



   * Name of drug: 

Date you started taking this drug:

Date you stopped taking this drug:

Please describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Loryna side effects lawsuit, birth control medicine, heart attacks

Loryna Birth Control Side Effects Lawsuit

Loryna (drospirenone/ethinyl estradiol) Side Effects, Birth Control Pills, Lawsuits, Lawyers | Heart Attsck, Blood Clots, Deep Vein Thrombosis, Pulmonary Embolism, Hyperkalemia, Strokes, Death, Gall Bladder Damage

If you have used the Loryna birth control pill and have suffered side effects such as: blood clot, pulmonary embolism, stroke or heart attack, the defective drug attorneys at Parker Waichman LLP would like to speak with you. Loryna, a synthetic form of progestin called drospirenone has been associated with serious side effects and health problems. A growing body of research has found that women who use birth control pills like Loryna face a greater danger of experiencing venous thromboembolism (VTE) (blood clot) compared to women who use pills made with another form of progestin. Loryna blood clots may lead to even more serious problems, including strokes, pulmonary embolism, and deep vein thrombosis side effects.

If you or a loved one suffered a blood clot, pulmonary embolism, stroke or heart attack side effect while using Loryna, you may be entitled to compensation. Lawyers at Parker Waichman LLP who investigate defective drugs are offering free consultations to victims of Loryna side effects concerning a potential personal injury lawsuit. To learn how our Loryna injury lawyers can help you, please contact us online today or call us at 1-800-YOURLAWYER (1-800-968-7529).

Loryna Birth Control Side Effects: Heart Attacks, Blood Clots, Strokes, Death, Deep Vein Thrombosis, Pulmonary Embolism

Loryna is a generic version of the popular birth control pill known as Yaz/Yasmin. Made by Sandoz, Loryna was approved by the U.S. Food & Drug Administration (FDA) in May 2011. In addition to preventing pregnancy, Loryna may be used to treat symptoms of premenstrual dysphoric disorder (PMDD) in women over 14 who also desire contraception. It is also approved to treat acne in women over 14 who require birth control.

According to the FDA, drospirenone can lead to hyperkalemia, a condition caused by excessive amounts of potassium in the blood, in certain high risk patients. This condition may result in potentially serious heart and health problems.

Side effects that have been associated with drospirenone birth control pills include:

  • Blood Clots
  • Deep Vein Thrombosis (DVT)
  • Venous Thromboembolism (VTE)
  • Pulmonary Embolism (PE)
  • Hyperkalemia
  • Stroke
  • Cerebrovascular Accidents (CVA)
  • Heart Attack
  • Gallbladder Disease / Injury (cholecystitis)
  • Death

Loryna and Blood Clots

At the time of Loryna's approval, Yaz/Yasmin and other drospirenone contraceptives were controversial because of their association with serious side effects, including blood clots, heart attacks and strokes. At the time of the Loryna approval, Yaz and other birth control pills made with drospirenone had already been named in more than 8,000 lawsuits alleging the contraceptives caused women to suffer serious and deadly side effects.

Loryna contains the same active ingredients as Yaz/Yasmin, it is likely that Loryna users will be at greater risk of suffering these same side effects. Though all birth control pills put women at a higher risk of blood clots, evidence is accumulating that those made with drospirenone increase this risk even more.

Just weeks after the FDA approved Loryna, the agency announced it was monitoring the safety of drospirenone birth control pills after two studies published in the British Medical Journal indicated women taking these drugs are approximately 2.5 times more likely to develop blood clots than women taking other forms of birth control pills.

In addition to the British Medical Journal studies, two earlier studies have found that birth control pills made with drospirenone increase the risk of blood clots. Two other studies, reportedly funded by Bayer, the company that makes Yaz, found no increased risk.

Legal Help for Victims of Loryna Side Effects

If you or someone you love took Loryna and suffered from serious side effects, including blood clots, deep vein thrombosis, pulmonary embolism, stroke, heart attack, or hyperkalemia, you have valuable legal rights. Please fill out our online form, or call 1-800-YOURLAWYER (1-800-968-7529) to discuss your case with our Loryna attorneys.


LorynaRSS Feed

FDA Says Yaz, Yasmin May Up Blood Clot Risks, Orders Label Changes for Drospirenone Birth Control Pills

Apr 11, 2012 | Parker Waichman LLP
The U.S. Food & Drug Administration (FDA) announced yesterday that it has finished reviewing a number of studies examining the link between Yaz, Yasmin and similar birth control pills and blood clots.   According to the agency, its review indicated that drospirenone-containing birth control pills like Yaz and Yasmin may pose a higher risk of blood clots compared to oral contraceptives made with other birth control pills.   In a Drug Safety Communication issued late...

70 Yaz Side Effects Lawsuits Settled as of February, Bayer Says

Mar 12, 2012 | Parker Waichman LLP
The first Yaz side effects lawsuits have reportedly been settled. According to Bayer's latest annual report, the company had resolved 70 lawsuits alleging the Yaz birth control pill caused blood clots, heart attacks, strokes and other serious side effects as of February 13, 2012.  According to the "Legal Risk" section of the  annual report, more than 11,300 lawsuits have been filed over its popular Yaz and Yasmin contraceptives, as well as generic versions of the drugs, Ocella and...

FDA Yaz, Yasmin Advisors Had Relationships with Bayer

Jan 11, 2012 | Parker Waichman LLP
Last month, an advisory panel for the U.S. Food & Drug Administration (FDA) voted to recommend by a four vote (15-11) margin that the benefits of Yaz, Yasmin and similar pills made with the synthetic progestin, drospirenone, outweighed their risk of dangerous blood clots. Now it's been learned that three of the FDA advisors who voted with the majority had ties to Bayer AG, the maker of the drugs, that were not disclosed by the agency.According to a report from The Wall Street Journal, those...

Yaz, Yasmin Blood Clot Risk Warnings Need to be Stronger, FDA Advisors Say

Dec 9, 2011 | Parker Waichman LLP
Two U.S. Food & Drug Administration (FDA) committees voted overwhelmingly yesterday to recommend stronger label warnings for Yaz, Yasmin and similar oral contraceptives regarding their possible association with blood clots.  The outside advisors voted 21-5 that current label warnings for Yaz, Yasmin and other pills made with the progestin, drospirenone, are inadequate and need to include clearer information about data that have linked the  pills to a higher risk of blood clots.The...

Yaz, Yasmin Blood Clot Risk Prompts Push for Stricter Warnings

Dec 7, 2011 | Parker Waichman LLP
U.S. Food & Drug Administration (FDA)  reviewers are pushing for stronger blood clot warnings for Yaz, Yasmin, and other birth control pills that contain drospirenone.  In a report posted on the agency website yesterday, FDA reviewers said that evidence linking Yaz, Yasmin and similar oral contraceptives to an increased risk of blood clots is conflicting, but could not be ruled out.The FDA report was released in advance of tomorrow's joint meeting for the FDA's Reproductive Health...

More Loryna News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo